← Back to inventory
Wolters Kluwer Pharmacy, Drug Diversion, and Infection Prevention Modules* (Only this or line below)
OrthoNebraska · MGP
Overview
- Department
- Pharmacy - 6160
- Strategic Imperative
- Operational Excellence & Quality
- Sponsor / Owner
- Beth Gard
- Project Manager
- Chris Vollmuth
- Ideal Team
- Chris Vollmuth, IT, Kristi Behrens, Mamie Thamer, Christine Ellett, Ad Hod IT
- Preferred Sprint
- —
- Priority
- 3. Medium Business Impact
- Priority Payoff
- High Benefit / High Effort
- Core Process
- Patient Journey
- Core Process Category
- —
- % Complete
- —
- Resources
- IT
Objective & KPI
- Objective
- Improve pharmacy surveillance of written orders to ensure proper dosing based on pt age, comorbidities, renal, and hepatic function by using rules based logic and best practices. Improve Drug Diversion surveillance by monitoring EMR and Omnicell transactions. Analyzes all providers and nursing staff to identify diversion patterns. Improve IP surveillance by identifying HAIs (healthcare associated infections) and analyzing treatment regimens and alerting based on IP rules.
- Goal / Output
- Improve patient safety, drug safety and reduce organizational risk.
- KPI
- Incident reporting, regulatory compliance (NSHN data).
- Notes
- Annual Contract for all three modules. 5% annual increase.
Financial Impact
- 2026 Op. (Exp.)
- —
- 2026 Op. (Act.)
- —
- 2026 Cap. (Exp.)
- $34,925
- 2026 Cap. (Act.)
- —
- 2027 Op. (Exp.)
- —
- 2027 Cap. (Exp.)
- $36,671
- Capital Priority
- —
- Confidence
- 100%
Dependencies
Depends on (upstream)
No prerequisites recorded.
Blocks / feeds (downstream)
Nothing waiting on this project.
Status History (0)
No status updates recorded.
Archive & Remove
Hides it from active views; fully reversible. Use this for canceled or on-hold work.